Cue Biopharma, Inc. (CUE ... This company is expected to post quarterly loss of $0.74 per share in its upcoming report, which represents a year-over-year change of +2.6%. The consensus EPS ...
3 天
Zacks Investment Research on MSNCue Biopharma, Inc. (CUE) Reports Q4 Loss, Misses Revenue EstimatesCue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.28 per share a year ago. These figures ...
Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.28 per share a year ago. These ...
Gold prices edged up on Wednesday as investors sought the comfort of the safe-haven metal in anticipation of the potential ...
This might prove to be the night the Ange Postecoglou dream died as the Tottenham Hotspur head coach took on his own ...
And also like three trolls cheekily declaring it should "raise the price", because of course. You've probably seen the ...
在该公司发布的最新财报中,公司每股收益为$-0.130,总营收为$1.58M,而此前英为财情Investing.com对分析师的调查显示,分析师预期该公司的营收为$1.9M,每股收益为$-0.086.
Market reversal spotted! Analyze last week's bearish trends, tariff impacts, and potential trade opportunities amid policy ...
’Tis the season for pretty pastels in all of their forms—but if you really want to stay on-trend, go for butter yellow. The ...
Gurugram: “I know when I play my best, I’m one of the best players in the world,” declared Eugenio Chacarra. He had a lot to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果